Substance,Type of TRV,TRV Value,Study Details,"Threshold/
Non-threshold
Endpoint",TRV Derivation Method,"Critical
Effect(s)","Carcinogenicity
Classification",Source
"Chromium,
trivalent",Oral TDI,"1.5E+00
mg/kg -day
BW","Study Type: chronic
Species: male and female BD rats
Mode of Administration: diet
Exposure Regime: chromic oxide (CrO)
2 3
in diet: 0% (control), 1%, 2%, or 5%,
5 days/week, for a total of 600 feedings;
average total amounts of ingested CrO
2 3
were 360, 720, and 1800 g/kg for
BW
each treatment group, respectively
Duration: 840 days
Uncertainty Factors: 1000 (10 for
intraspecies variability and 10 for
interspecies variability, and 10 for
database deficiencies)","NOAEL = 5% CrO
2 3
in diet, corresponding
to an average total
dose of 1,800 g/kg
BW
(over 600 meals)","NOAEL was
converted to a NOAEL
for Cr(III) using a factor of
0.6849 g Cr(III) / g CrO
2 3
and
adjusted for
continuous exposure
NOAEL Cr (III) =
adj
1468 mg Cr(III)/kg -day
BW
TDI =
NOAEL Cr(III) / (UF)
adj","No effects
observed at
any dose level","CEPA: Group VI
unclassifiable with
respect to
carcinogenicity
to humans
(EC and HC, 1994c)
IARC: Group 3
not classifiable
with respect to
carcinogenicity
to humans
(IARC, 1990)
US EPA IRIS:
Group D
not classifiable
with respect
to human
carcinogenicity
(US EPA, 1998c)","US EPA, 1998c
(based on
Ivankovic and
Preussmann,
1975)"
"Chromium,
trivalent",Inhalation TC,"1.0E-04
mg/m3
intermediate
duration
minimal risk
level for
soluble Cr(III)
particulates","Study Type: subchronic
Species: male and female CDF rats
Mode of Administration: inhalation
(nose only)
Exposure Regime: nose-only inhalation
exposure to chromic oxide (CrO) or
2 3
basic chromium sulfate (CrHOS) dusts,
5
at measured concentrations of 0, 3, 10,
or 30 mg chromium(III)/m3 for 6 hours/
day, 5 days/week
Duration: 13 weeks
Uncertainty Factors: 300 (10 for use of
a LOAEL, 10 for intraspecies variability,
and 3 for interspecies variability)","LOAEL =
3 mg Cr (III)/m3","LOAEL adjusted for
intermittent exposure
(0.54 mg Cr (III)/m3) and
converted to a LOAEL
HEC
using a regional deposited
dose ratio for the
respiratory tract
LOAEL =
HEC
0.04 mg/m3
Inhalation TC =
LOAEL Cr(III) / UF
HEC","Respiratory
tract toxicity",,"ATSDR, 2012
(based on
Derelanko et al.,
1999)"
